Easywell Biomedicals Financials
| 1799 Stock | TWD 67.90 3.10 4.78% |
Easywell |
Understanding current and past Easywell Biomedicals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Easywell Biomedicals' financial statements are interrelated, with each one affecting the others. For example, an increase in Easywell Biomedicals' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Easywell Biomedicals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Easywell Biomedicals. Check Easywell Biomedicals' Beneish M Score to see the likelihood of Easywell Biomedicals' management manipulating its earnings.
Easywell Biomedicals Stock Summary
Easywell Biomedicals competes with Universal Vision, Excelsior Medical, Hi Clearance, Brighten Optix, and United Orthopedic. Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan. EASYWELL BIOMEDICAL operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Business Address | No10, Yanfa 2nd |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.easywellbio.com |
| Phone | 886 3 666 9596 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Easywell Biomedicals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Easywell Stock, because this is throwing your money away. Analyzing the key information contained in Easywell Biomedicals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Easywell Biomedicals Key Financial Ratios
There are many critical financial ratios that Easywell Biomedicals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Easywell Biomedicals reports annually and quarterly.Easywell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Easywell Biomedicals's current stock value. Our valuation model uses many indicators to compare Easywell Biomedicals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Easywell Biomedicals competition to find correlations between indicators driving Easywell Biomedicals's intrinsic value. More Info.Easywell Biomedicals is rated fifth in ebitda category among its peers. It also is rated fifth in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easywell Biomedicals' earnings, one of the primary drivers of an investment's value.Easywell Biomedicals Systematic Risk
Easywell Biomedicals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Easywell Biomedicals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Easywell Biomedicals correlated with the market. If Beta is less than 0 Easywell Biomedicals generally moves in the opposite direction as compared to the market. If Easywell Biomedicals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Easywell Biomedicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Easywell Biomedicals is generally in the same direction as the market. If Beta > 1 Easywell Biomedicals moves generally in the same direction as, but more than the movement of the benchmark.
Easywell Biomedicals Thematic Clasifications
Easywell Biomedicals is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Easywell Biomedicals November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Easywell Biomedicals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Easywell Biomedicals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Easywell Biomedicals based on widely used predictive technical indicators. In general, we focus on analyzing Easywell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Easywell Biomedicals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.35) | |||
| Maximum Drawdown | 19.47 | |||
| Value At Risk | (9.84) | |||
| Potential Upside | 7.81 |
Additional Tools for Easywell Stock Analysis
When running Easywell Biomedicals' price analysis, check to measure Easywell Biomedicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easywell Biomedicals is operating at the current time. Most of Easywell Biomedicals' value examination focuses on studying past and present price action to predict the probability of Easywell Biomedicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easywell Biomedicals' price. Additionally, you may evaluate how the addition of Easywell Biomedicals to your portfolios can decrease your overall portfolio volatility.